This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2002.
Location History:
- Wilmington, DE (US) (2002)
- Newark, DE (US) (2002)
Company Filing History:
Years Active: 2002
Title: The Innovations of Robert Frank Dedinas
Introduction
Robert Frank Dedinas is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmacology, particularly in the development of receptor antagonists. With a total of 2 patents to his name, Dedinas continues to push the boundaries of scientific research and innovation.
Latest Patents
Dedinas's latest patents include "Naphthalenecarboxamides as tachykinin receptor antagonists" and "N-substituted naphthalene carboxamides as neurokinin-receptor antagonists." These inventions are pivotal in the exploration of new therapeutic avenues for various medical conditions.
Career Highlights
Currently, Dedinas is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on advancing drug discovery and development, contributing to the company's mission of improving patient outcomes through innovative medicines.
Collaborations
Dedinas has collaborated with esteemed colleagues such as Keith Russell and Peter Robert Bernstein. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Robert Frank Dedinas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of teamwork in advancing medical science.